Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00080219" target="_blank" >RIV/65269705:_____/24:00080219 - isvavai.cz</a>
Výsledek na webu
<a href="https://ashpublications.org/blood/article/143/19/1891/514792/Diagnosis-prognostic-factors-and-assessment-of-ALL" target="_blank" >https://ashpublications.org/blood/article/143/19/1891/514792/Diagnosis-prognostic-factors-and-assessment-of-ALL</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1182/blood.2023020794" target="_blank" >10.1182/blood.2023020794</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Popis výsledku v původním jazyce
Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk strati fi cation as well as de fi nitions of endpoints and outcomes. Aspects of treatment, management of subgroups and speci fi c situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to de fi ne principles as a basis for future collaborative research.
Název v anglickém jazyce
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Popis výsledku anglicky
Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk strati fi cation as well as de fi nitions of endpoints and outcomes. Aspects of treatment, management of subgroups and speci fi c situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to de fi ne principles as a basis for future collaborative research.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30205 - Hematology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Blood
ISSN
0006-4971
e-ISSN
1528-0020
Svazek periodika
143
Číslo periodika v rámci svazku
19
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
12
Strana od-do
1891-1902
Kód UT WoS článku
001239871000001
EID výsledku v databázi Scopus
—